Balaji Amines Limited
NSE: BALAMINES · Specialty Chemicals
Snapshot
Unlock Balaji Amines Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Balaji Amines Limited is a prominent Indian manufacturer of aliphatic amines, specialty chemicals, and pharmaceutical excipients. The company serves diverse sectors including pharmaceuticals, agrochemicals, and water treatment, while maintaining minor operations in the hospitality and lighting industries.
Business Model
The company generates revenue primarily through the large-scale production and sale of chemical derivatives, leveraging its manufacturing facilities to supply both domestic and international markets. It operates a diversified model that includes a core chemical business supplemented by hospitality and CFL lamp manufacturing.
Growth Outlook
Growth is driven by the increasing demand for specialty chemicals in the pharmaceutical and agrochemical sectors, alongside expansion into international markets. The company continues to focus on its portfolio of derivatives and excipients to capture higher value-add opportunities.
Key Risks
- Raw Material Price Volatility. Fluctuations in the prices of key petrochemical feedstocks can significantly impact the company's operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate high capital expenditure for compliance.
- Geopolitical and Export Risks. As an exporter to multiple international markets, the company is exposed to trade barriers, currency fluctuations, and geopolitical instability.
- Cyclical Demand. The company's performance is tied to the cyclical nature of end-user industries such as agrochemicals and pharmaceuticals.
Start your research today
Unlock AI insights, financials, peers and live data on Balaji Amines Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,523 Cr
TTM · consolidated
NET PROFIT
₹211 Cr
TTM · consolidated
EPS
₹63.28
TTM · consolidated
RETURN ON EQUITY
11.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
13.3%
TTM · consolidated
P/E
32.4×
Q1 FY27 · consolidated
EV/EBITDA
21.1x
Q1 FY27 · consolidated
EBITDA MARGIN
23.1%
TTM · consolidated
NET PROFIT MARGIN
17.1%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Balaji Amines LimitedBALAMINES | ₹7,359 Cr | 32.4× | 21.08 | 11.1% | 23.1% | 11.0% | 13.3% | +46.4% |
Clean Science and Technology Ltd.CLEAN | ₹8,892 Cr | 36.6× | 22.55 | -0.4% | 40.0% | 15.5% | 20.4% | -26.8% |
Galaxy Surfactants LimitedGALAXYSURF | ₹7,878 Cr | 23.8× | 12.90 | 27.1% | 10.7% | 13.9% | 17.7% | +6.7% |
Fineotex Chemical LimitedFCL | ₹6,616 Cr | 16.8× | 32.49 | 91.4% | 20.0% | 18.4% | 22.0% | -77.7% |
Neogen Chemicals LimitedNEOGEN | ₹6,550 Cr | 181.1× | 48.36 | 18.0% | 17.6% | 4.4% | 9.7% | +59.2% |
Archean Chemical Industries LimitedACI | ₹5,859 Cr | 60.2× | 24.91 | -0.4% | 22.6% | 5.0% | 7.2% | -31.5% |
As of Q1 FY27
Financials
Balaji Amines Limited
NSE: BALAMINES · Specialty Chemicals
Snapshot
Unlock Balaji Amines Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Balaji Amines Limited is a prominent Indian manufacturer of aliphatic amines, specialty chemicals, and pharmaceutical excipients. The company serves diverse sectors including pharmaceuticals, agrochemicals, and water treatment, while maintaining minor operations in the hospitality and lighting industries.
Business Model
The company generates revenue primarily through the large-scale production and sale of chemical derivatives, leveraging its manufacturing facilities to supply both domestic and international markets. It operates a diversified model that includes a core chemical business supplemented by hospitality and CFL lamp manufacturing.
Growth Outlook
Growth is driven by the increasing demand for specialty chemicals in the pharmaceutical and agrochemical sectors, alongside expansion into international markets. The company continues to focus on its portfolio of derivatives and excipients to capture higher value-add opportunities.
Key Risks
- Raw Material Price Volatility. Fluctuations in the prices of key petrochemical feedstocks can significantly impact the company's operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate high capital expenditure for compliance.
- Geopolitical and Export Risks. As an exporter to multiple international markets, the company is exposed to trade barriers, currency fluctuations, and geopolitical instability.
- Cyclical Demand. The company's performance is tied to the cyclical nature of end-user industries such as agrochemicals and pharmaceuticals.
Start your research today
Unlock AI insights, financials, peers and live data on Balaji Amines Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,523 Cr
TTM · consolidated
NET PROFIT
₹211 Cr
TTM · consolidated
EPS
₹63.28
TTM · consolidated
RETURN ON EQUITY
11.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
13.3%
TTM · consolidated
P/E
32.4x
Q1 FY27 · consolidated
EV/EBITDA
21.1x
Q1 FY27 · consolidated
EBITDA MARGIN
23.1%
TTM · consolidated
NET PROFIT MARGIN
17.1%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27